Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of RO7434656 for Patients with Primary IgA Nephropathy at High Risk of Progression
GermanyStudy Comparing Upadacitinib and Adalimumab for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to a Single TNF Inhibitor
GermanyStudy on Alteplase for Vision Recovery in Patients with Acute Central Retinal Artery Occlusion
GermanyStudy of Sacituzumab Govitecan for Patients with Advanced Esophagogastric Cancer
GermanyStudy on the Safety and Effects of Forimtamig, Tocilizumab, and Daratumumab in Patients with Relapsed or Refractory Multiple Myeloma
GermanyStudy Comparing Pembrolizumab Alone and with Sacituzumab Govitecan for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels
GermanyStudy on the Safety and Effectiveness of SXR1096 Cream for Patients with Netherton Syndrome
GermanyStudy of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma
GermanyStudy on Upadacitinib for Children with Moderate to Severe Ulcerative Colitis
GermanyStudy on the Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Children with Late-onset Pompe Disease
GermanyStudy of Ixekizumab and Adalimumab for Children with Juvenile Idiopathic Arthritis, Including Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis
GermanyStudy on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
